Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I M Bush

Showing results (41-50 of 80) with videos related to

Pageof 8
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1974
The effect of estrogen on the incorporation of 3H-thymidine by PHA-stimulated human peripheral blood lymphocytesR J Ablin, G R Bruns, P Guinan, et al.
Current Therapeutic Research, Clinical and Experimental|August 1, 1974
"Immunostaging" as a guideline to immunotherapy in malignancyR J Ablin, P D Guinan, G R Bruns, et al.
Lancet (London, England)|August 25, 1973
B.C.G. immunotherapy in carcinoma of prostateP Guinan, I M Bush, T John, et al.
Oncology|January 1, 1974
Migration-inhibitory effect of serum from patients with prostatic cancerR J Ablin, G R Bruns, P D Guinan, et al.
Urology|December 1, 1974
Editorial: "immunostaging" patients with malignant diseaseP D Guinan, R J Ablin, G R Bruns, et al.
Allergologia Et Immunopathologia|November 1, 1975
Inhibition of leukocyte migration by serum from patients with prostatic cancerR J Ablin, P D Guinan, I M Bush, et al.
Journal of Reproductive Immunology|February 1, 1980
Effect of human seminal plasma on tumour-associated immunity in patients with adenocarcinoma of the prostateR J Ablin, R A Bhatti, I M Bush, et al.
European Urology|January 1, 1980
Suppression of tumor-associated immunity by human seminal plasma and its possible role in the natural history of prostatic cancerR J Ablin, R A Bhatti, I M Bush, et al.
Lancet (London, England)|August 17, 1974
Letter: Afferent blockage, oestrogenic therapy, and malignancyR J Ablin, G R Bruns, P D Guinan, et al.
Progress in Experimental Tumor Research|January 1, 1974
Immunologic considerations of carcinoma of the prostateP Guinan, I M Bush, N Sadoughi, et al.
Pageof 8

Showing results (41-50 of 80) with videos related to

Sort By:
Pageof 8
Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1974
The effect of estrogen on the incorporation of 3H-thymidine by PHA-stimulated human peripheral blood lymphocytesR J Ablin, G R Bruns, P Guinan, et al.
Current Therapeutic Research, Clinical and Experimental|August 1, 1974
"Immunostaging" as a guideline to immunotherapy in malignancyR J Ablin, P D Guinan, G R Bruns, et al.
Lancet (London, England)|August 25, 1973
B.C.G. immunotherapy in carcinoma of prostateP Guinan, I M Bush, T John, et al.
Oncology|January 1, 1974
Migration-inhibitory effect of serum from patients with prostatic cancerR J Ablin, G R Bruns, P D Guinan, et al.
Urology|December 1, 1974
Editorial: "immunostaging" patients with malignant diseaseP D Guinan, R J Ablin, G R Bruns, et al.
Allergologia Et Immunopathologia|November 1, 1975
Inhibition of leukocyte migration by serum from patients with prostatic cancerR J Ablin, P D Guinan, I M Bush, et al.
Journal of Reproductive Immunology|February 1, 1980
Effect of human seminal plasma on tumour-associated immunity in patients with adenocarcinoma of the prostateR J Ablin, R A Bhatti, I M Bush, et al.
European Urology|January 1, 1980
Suppression of tumor-associated immunity by human seminal plasma and its possible role in the natural history of prostatic cancerR J Ablin, R A Bhatti, I M Bush, et al.
Lancet (London, England)|August 17, 1974
Letter: Afferent blockage, oestrogenic therapy, and malignancyR J Ablin, G R Bruns, P D Guinan, et al.
Progress in Experimental Tumor Research|January 1, 1974
Immunologic considerations of carcinoma of the prostateP Guinan, I M Bush, N Sadoughi, et al.
Pageof 8